FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Real-time Bid/Ask 12:14:33 28/05/2024 pm IST | ||
| 4.57 EUR / 4.87 EUR | +2.39% |
|
| Current month | -14.94% | ||
| 1 month | +2.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 4.61 | +2.90% |
| 24/24/24 | 4.48 | -28.43% |
| 23/24/23 | 6.26 | +0.48% |
| 22/24/22 | 6.23 | -21.73% |
| 21/24/21 | 7.96 | +1.02% |
Delayed Quote Börse Stuttgart
Last update May 27, 2024 at 10:19 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4CZ8 |
| ISIN | DE000JK4CZ81 |
| Date issued | 22/03/2024 |
| Strike | 190.8 $ |
| Maturity | Unlimited |
| Parity | 5.85 : 1 |
| Emission price | 10.17 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.04 € |
|---|---|
| Lowest since issue | 2.34 € |
| Spread | 0.3 € |
| Spread % | 6.17% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
217.8
USD
Average target price
286.1
USD
Spread / Average Target
+31.33%
- Stock Market
- Certificates
- Certificat
